Zoll Zeroes In On TherOx, Acquires SSO2 Therapy
Executive Summary
Just months after receiving USA FDA approval for its SuperSaturated Oxygen (SSO2) Therapy for heart-attack treatment, Californian company TherOx has been acquired by Zoll Medical for an undisclosed sum.